IndraLab

Statements

(-)-epigallocatechin 3-gallate inhibits MYD88. 7 / 7
| 7
reach
"A study also demonstrated that EGCG blocks both the MyD88-dependent and TRIF-dependent signaling pathways of TLRs in RAW264.7 cells (89)."
37701897
reach
"3) EGCG (20mg/Kg, i.p.), 1, 24 and 48h after paraquat administration in mice, attenuates ALI, the activation of NF-kappaB and upregulation of toll like receptor 2, 4 and 9, as well as their adaptors MyD88 and TRAF6 in the lung."
34054222
reach
"A study also has shown that EGCG inhibits MyD88 dependent signaling pathways and TIR domain containing adaptor inducing IFN-beta (TRIF)-dependent signaling pathways of TLRs in RAW264.7 cells [XREF_BIBR]."
30213077
reach
"EGCG inhibited the activation of NF-κB and the upregulation of TLR 2, 4 and 9 as well as their adaptors MyD88 and TRAF6 in the lungs following PQ challenge."
30359726
reach
"Specifically, EGCG targets and inhibits myeloid differentiation factor 88 (MyD88)- and Toll/interleukin-1 receptor (TIR)-domain-containing adaptor protein inducing interferon beta (TRIF)-dependent signal pathways of TLRs, which are key to the production of inflammatory molecules."
38704088
reach
"In vivo and in vitro studies have demonstrated that EGCG can inhibit the activation of NF-κB and subsequent inflammatory target gene expression via modulation both MyD88- and TRIF-dependent signaling [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
22173123
reach
"In addition, EGCG can finally induce the degradation of TLR-4 co-factor MyD88 adaptor-like (MAL) protein, which links TLR-4 signaling to NF-κB activation, by enhancing the activation of the suppressor of cytokine signaling 1 (SOCS1), which dampens inflammatory responses as a kind of compensatory anti-inflammatory pathway [14] (Figure 5)."
28335502